)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Vistin Pharma (VISTN) investor relations material
Vistin Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary31 Oct, 2025
Executive summary
Q3 2025 revenue reached NOK/MNOK 109 million, up 3% year-over-year, driven by a 10% increase in sales volume.
Year-to-date revenue is NOK/MNOK 342 million, an 8% increase from the prior year.
EBITDA for Q3 was NOK/MNOK 28 million, slightly down from last year, but year-to-date EBITDA rose 16% to NOK/MNOK 89 million.
Net profit for Q3 was NOK/MNOK 18.5 million, up from NOK/MNOK 16.6 million in Q3 2024.
Achieved all-time high production volume of 1,600 metric tons of metformin in the quarter.
Financial highlights
Gross margin in Q3 was 68%, supported by stable production and scale benefits.
EBITDA margin for Q3 was 26%.
Net finance income in Q3 was positive, mainly from FX hedging contracts, at MNOK 2.4.
Total assets at quarter-end were NOK 425 million, up from NOK 388 million a year ago.
Q3 net income was MNOK 18.5, up from MNOK 16.6 in Q3 2024.
Outlook and guidance
Metformin market expected to grow 4–6% annually; company aims to ramp up production to over 7,000 metric tons by 2026.
No current impact from U.S. tariff discussions, but situation is being monitored.
Long-term renewable energy agreement in place until 2032 ensures predictable, green power supply.
Focus remains on cost control, commercial execution, and optimizing capacity.
Attractive long-term growth potential as new capacity is optimized.
Strategy for market share beyond 7k MT capacity
Q3 gross margin vs. EBITDA effect explanation
Potential supply chain impact from US tariffs
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Vistin Pharma earnings date
Q4 202512 Feb, 2026
Next Vistin Pharma earnings date
Q4 202512 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Vistin Pharma AS is a global pharmaceutical company that produces and markets active pharmaceutical ingredients. The company offers its products to an extensive network of third party manufacturers. In addition, the company develops its own formulations that are produced and marketed by the Vistin Pharma AS subsidiary. As well as producing bulk APIs, Vistin Pharma has a wide range of products in different stages of development that it expects will be launched in 2016.
Vistin Pharma has experienced continued growth in demand for its products, both due to the expansion of the pharma industry and from the increasing amount of specialised niche pharmaceuticals being developed. Its focus is on supplying products for diabetes and autoimmunity therapies as well as antibiotics. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage